AstraZeneca

Open: 68.64 Close: 68.27 Change: -0.37

How to get information about AstraZeneca Company Inc Stock without reading the whole internet.

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, analyst, say, Astrazeneca, Zacks, several, and the …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

American Trusts holdings in AstraZeneca were worth $358,000 as of its most recent SEC filing. American Trust has $358K position in Astrazeneca.

Today's News

Shares of AstraZeneca were 3.8% lower in afternoon trade despite several analysts saying results from a late-stage trial combining its drug Tagrisso with chemotherapy were a boost to the company as it seeks to compete with a rival Johnson & Johnson treatment. Astrazeneca PLC is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company is currently a Zacks Rank #3 (Hold) AstraZeneca recently partnered with Daiichi Sankyo on August 8, 2023. American Trusts holdings in AstraZeneca were worth $358,000 as of its most recent SEC filing. American Trust has $358K position in Astrazeneca plc (nasdaq:azn) - defense world. astrazeneca details pfs data for tagrisso, chemo combo in phiii flaura2 trial – endpoints news. You may report side effects. AstraZeneca shares were down 3.3% at 1128 GMT, with two analysts citing a report in the Mail on Sunday saying the drugmakers Chief Executive Pascal Soriot had said privately to friends and advisers that he may leave the company as soon as next year. The drugmaker declined to comment. AstraZeneca/CanSino mRNA deal; Tigermed Hong Kong HQ; Biotech-Friendly Tax Breaks. G7 group warns of threat of “economic coercion” from China and US to scrutinise healthcare. AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment. Company has agreed a 15-year partnership with Future Biogas to establish the UKs first unsubsidised industrial-scale supply of biomethane gas. AstraZeneca inked new deal with Verge Genomics to use artificial intelligence (AI) to discover and create new drugs to take on a slate of different diseases. AstraZeneca is a global biopharmaceutical company with several leading pharmaceutical products. As of 2022, the highest proportion of AstraZecas employees was based in Europe. The global office and corporate headquarters is located in Cambridge in the United Kingdom. AstraZeneca revenue was $11.42 billion in the second quarter of 2023, up 6% from the prior quarter and beating analysts consensus estimates by $0.4 billion. Wall Street Street is beginning to experience pressure due to the appearance of an increasing number of biosimilars on the market. Astrazeneca has been one of the most searched-for stocks on Zacks.com lately. The company is trading at a discount to its peers. The Zacks Rank #3 (Hold) is a Zacks Equity Research   published on September.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

The game is changing. There is a new strategy to evaluate AstraZeneca fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, analyst, say, Astrazeneca, Zacks, several, and the most common words in the summary are: astrazeneca, astrazenecas, see, company, subscribe, share, stock, . One of the sentences in the summary was: American Trusts holdings in AstraZeneca were worth $358,000 as of its most recent SEC filing. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #astrazenecas #see #company #subscribe #share #stock.